INVENTVACC BIOLOGICALS INC.
🇨🇦Canada
- Country
- 🇨🇦Canada
- Ownership
- Private
- Established
- 2016-01-01
- Employees
- 11
- Market Cap
- -
- Website
- https://www.inventvacc.com
A Study to Evaluate Safety and Immunogenicity of Haemophilus Influenzae Serotype A Vaccine
Phase 1
Active, not recruiting
- Conditions
- Invasive Haemophilus Influenzae DiseaseHaemophilus Influenzae Meningitis
- Interventions
- Biological: Haemophilus influenzae type a (Hia) glycoconjugate vaccine
- First Posted Date
- 2024-06-18
- Last Posted Date
- 2025-04-30
- Lead Sponsor
- InventVacc Biologicals Inc.
- Target Recruit Count
- 30
- Registration Number
- NCT06465420
- Locations
- 🇨🇦
Canadian Center for Vaccinology (CCfV), Halifax, Nova Scotia, Canada
🇨🇦McGill University Health Centre (MUHC) Vaccine Study Centre, Montreal, Quebec, Canada
© Copyright 2025. All Rights Reserved by MedPath